Tarja K. Nevanen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tarja K. Nevanen has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Andreas Hirsch
Department of Chemistry and Pharmacy Chair of Organic Chemistry II Friedrich‐Alexander‐Universität Erlangen‐Nürnberg Nikolaus‐Fiebiger‐Straße 10 91058 Erlangen Germany
2 shared publications - Bettina Glahn-Martínez
Department of Analytical Chemistry, Faculty of Chemistry, Universidad Complutense de Madrid, Plaza de las Ciencias, Ciudad Universitaria, Madrid, 28040, Spain
2 shared publications Cian Bartlam
Institute of Physics EIT 2 Faculty of Electrical Engineering and Information Technology University of the Bundeswehr Munich & SENS Research Center Werner-Heisenberg-Weg 39 85 577 Neubiberg Germany
2 shared publications- Elena Benito-Peña
Department of Analytical Chemistry, Universidad Complutense de Madrid, Madrid, Spain
2 shared publications - Fernando Navarro Villoslada
Department of Analytical Chemistry, Faculty of Chemistry, Universidad Complutense de Madrid, Plaza de las Ciencias, Ciudad Universitaria, Madrid, 28040, Spain
2 shared publications - Fernando Pradanas-González
Department of Analytical Chemistry, Faculty of Chemistry, Universidad Complutense de Madrid, Plaza de las Ciencias, Ciudad Universitaria, Madrid, 28040, Spain
2 shared publications
Latest Publications
- Open Access
- 23 September 2025
- Published by Springer Nature in Microchimica Acta
- Vol. 192 (10) , 1
Correction: Biotechnology-enhanced immunoassay for accurate determination of HT-2 toxin in edible insect samples
- 23 September 2025
- Published by Springer Nature in Microchimica Acta
- Vol. 192 (10) , 1
Open AccessCorrection: Biotechnology-enhanced immunoassay for accurate determination of HT-2 toxin in edible insect samples
- Open Access
- 16 April 2025
- Published by Springer Nature in Microchimica Acta
- Vol. 192 (5) , 1-12
Biotechnology-enhanced immunoassay for accurate determination of HT-2 toxin in edible insect samples
Consumption of edible insects is common in non-Western countries of Africa, Asia, Oceania, and Latin America. However, their consumption has significantly increased in Europe in recent years thanks to their remarkable nutritional properties. Edible insects provide a valuable source of high-quality proteins, fats, minerals, and vitamins. Nevertheless, the absence of global regulatory guidelines poses a risk associated with their consumption due to the potential presence of pathogens and contaminants, such as mycotoxins, which are toxic compounds produced by fungi and represent a major threat to food and feed safety. Our approach integrates advanced nanobiotechnology to develop fluorescent antibodies by conjugating a recombinant superfolder green fluorescent protein (sfGFP) with a single-chain antibody (scFv). This fusion allows for precise detection of the immune complex formed between the HT-2 toxin and a biotinylated anti-HT-2 antibody. Additionally, we employed advanced computational tools, including AlphaFold and MOE, to deepen our understanding of the binding interactions present in the immune complex, confirming the strong interaction between the Fab/HT-2 toxin immunocomplex and the scFv antibody fragment, in contrast to the weaker binding observed with the Fab/T-2 toxin and the scFv. The method demonstrates high sensitivity, with an EC50 of 10.3 ± 0.6 ng mL−1, a dynamic range of 3.4 ± 0.1 to 31 ± 3 ng mL−1, a limit of detection of 0.43 ng mL−1, and a limit of quantification of 1.2 ng mL−1 in buffer solution. The assay exhibited excellent precision, with a reproducibility of 4% and no cross-reactivity with other mycotoxins. Application to contaminated cricket flour yielded recoveries between 91 and 133%, with coefficients of variation from 6 to 13%. These results indicate that the developed immunoassay is highly sensitive, selective, and reliable for detecting HT-2 toxin in food matrices, providing a promising tool for mycotoxin screening in food safety. Graphical Abstract
- 16 April 2025
- Published by Springer Nature in Microchimica Acta
- Vol. 192 (5) , 1-12
Open AccessBiotechnology-enhanced immunoassay for accurate determination of HT-2 toxin in edible insect samples
Consumption of edible insects is common in non-Western countries of Africa, Asia, Oceania, and Latin America. However, their consumption has significantly increased in Europe in recent years thanks to their remarkable nutritional properties. Edible insects provide a valuable source of high-quality proteins, fats, minerals, and vitamins. Nevertheless, the absence of global regulatory guidelines poses a risk associated with their consumption due to the potential presence of pathogens and contaminants, such as mycotoxins, which are toxic compounds produced by fungi and represent a major threat to food and feed safety. Our approach integrates advanced nanobiotechnology to develop fluorescent antibodies by conjugating a recombinant superfolder green fluorescent protein (sfGFP) with a single-chain antibody (scFv). This fusion allows for precise detection of the immune complex formed between the HT-2 toxin and a biotinylated anti-HT-2 antibody. Additionally, we employed advanced computational tools, including AlphaFold and MOE, to deepen our understanding of the binding interactions present in the immune complex, confirming the strong interaction between the Fab/HT-2 toxin immunocomplex and the scFv antibody fragment, in contrast to the weaker binding observed with the Fab/T-2 toxin and the scFv. The method demonstrates high sensitivity, with an EC50 of 10.3 ± 0.6 ng mL−1, a dynamic range of 3.4 ± 0.1 to 31 ± 3 ng mL−1, a limit of detection of 0.43 ng mL−1, and a limit of quantification of 1.2 ng mL−1 in buffer solution. The assay exhibited excellent precision, with a reproducibility of 4% and no cross-reactivity with other mycotoxins. Application to contaminated cricket flour yielded recoveries between 91 and 133%, with coefficients of variation from 6 to 13%. These results indicate that the developed immunoassay is highly sensitive, selective, and reliable for detecting HT-2 toxin in food matrices, providing a promising tool for mycotoxin screening in food safety. Graphical Abstract
- Open Access
- 25 April 2023
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 62 (22) , e202219024
Functionalisation of Graphene Sensor Surfaces for the Specific Detection of Biomarkers
We report on a controllable and specific functionalisation route for graphene field‐effect transistors (GFETs) for the recognition of small physiologically active molecules. Key element is the noncovalent functionalisation of the graphene surface with perylene bisimide (PBI) molecules directly on the growth substrate. This Functional Layer Transfer enables the homogeneous self‐assembly of PBI molecules on graphene, onto which antibodies are subsequently immobilised. The sensor surface was characterised by atomic force microscopy, Raman spectroscopy and electrical measurements, showing superior performance over conventional functionalisation after transfer. Specific sensing of small molecules was realised by monitoring the electrical property changes of functionalised GFET devices upon the application of methamphetamine and cortisol. The concentration dependent electrical response of our sensors was determined down to a concentration of 300 ng ml −1 for methamphetamine.
- 25 April 2023
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 62 (22) , e202219024
Open AccessFunctionalisation of Graphene Sensor Surfaces for the Specific Detection of Biomarkers
We report on a controllable and specific functionalisation route for graphene field‐effect transistors (GFETs) for the recognition of small physiologically active molecules. Key element is the noncovalent functionalisation of the graphene surface with perylene bisimide (PBI) molecules directly on the growth substrate. This Functional Layer Transfer enables the homogeneous self‐assembly of PBI molecules on graphene, onto which antibodies are subsequently immobilised. The sensor surface was characterised by atomic force microscopy, Raman spectroscopy and electrical measurements, showing superior performance over conventional functionalisation after transfer. Specific sensing of small molecules was realised by monitoring the electrical property changes of functionalised GFET devices upon the application of methamphetamine and cortisol. The concentration dependent electrical response of our sensors was determined down to a concentration of 300 ng ml −1 for methamphetamine.
- Open Access
- 25 April 2023
- Published by Wiley in Angewandte Chemie
- Vol. 135 (22)
Functionalisation of Graphene Sensor Surfaces for the Specific Detection of Biomarkers
We report on a controllable and specific functionalisation route for graphene field‐effect transistors (GFETs) for the recognition of small physiologically active molecules. Key element is the noncovalent functionalisation of the graphene surface with perylene bisimide (PBI) molecules directly on the growth substrate. This Functional Layer Transfer enables the homogeneous self‐assembly of PBI molecules on graphene, onto which antibodies are subsequently immobilised. The sensor surface was characterised by atomic force microscopy, Raman spectroscopy and electrical measurements, showing superior performance over conventional functionalisation after transfer. Specific sensing of small molecules was realised by monitoring the electrical property changes of functionalised GFET devices upon the application of methamphetamine and cortisol. The concentration dependent electrical response of our sensors was determined down to a concentration of 300 ng ml −1 for methamphetamine.
- 25 April 2023
- Published by Wiley in Angewandte Chemie
- Vol. 135 (22)
Open AccessFunctionalisation of Graphene Sensor Surfaces for the Specific Detection of Biomarkers
We report on a controllable and specific functionalisation route for graphene field‐effect transistors (GFETs) for the recognition of small physiologically active molecules. Key element is the noncovalent functionalisation of the graphene surface with perylene bisimide (PBI) molecules directly on the growth substrate. This Functional Layer Transfer enables the homogeneous self‐assembly of PBI molecules on graphene, onto which antibodies are subsequently immobilised. The sensor surface was characterised by atomic force microscopy, Raman spectroscopy and electrical measurements, showing superior performance over conventional functionalisation after transfer. Specific sensing of small molecules was realised by monitoring the electrical property changes of functionalised GFET devices upon the application of methamphetamine and cortisol. The concentration dependent electrical response of our sensors was determined down to a concentration of 300 ng ml −1 for methamphetamine.
- Open Access
- 27 November 2022
- Published by Wiley in Advanced Materials Interfaces
- Vol. 10 (2)
Quantitative Mid‐Infrared Plasmonic Biosensing on Scalable Graphene Nanostructures
Graphene nanostructures, exhibiting tunable and nanoscale‐confined mid‐infrared (mid‐IR) plasmons, prevail as a powerful spectroscopic platform for novel surface‐enhanced molecular identification. Particularly, graphene shows exciting opportunities for biosensing applications due to its versatile functionalization methods with different biomolecular building blocks (e.g., enzymes, proteins, and DNA). Here, a quantitative bioassay based on the mid‐IR localized surface plasmon resonance (LSPR) modulation in functionalized graphene nanostructures is demonstrated. Specifically, vitamin B12 (vB12) using the specific recognition elements on modified graphene nanoribbons (i.e., pyrene linkers via π − π stacking + anti‐vB12 antibody fragments via amide bond) is detected. Different concentrations of vB12 spotted on an arrayed panel of a single chip are quantified by the graphene LSPR shifts, where a limit of detection (LOD) of 53.5 ng mL−1 is obtained. The upscaling potential of the bioassay using large area nanostructured graphene films produced by nanoimprinting 2D hole arrays is illustrated. The integration of quantitative bioassay with scalable graphene nanostructures shows promising routes of graphene‐based mid‐IR platforms toward prospective industrial applications.
- 27 November 2022
- Published by Wiley in Advanced Materials Interfaces
- Vol. 10 (2)
Open AccessQuantitative Mid‐Infrared Plasmonic Biosensing on Scalable Graphene Nanostructures
Graphene nanostructures, exhibiting tunable and nanoscale‐confined mid‐infrared (mid‐IR) plasmons, prevail as a powerful spectroscopic platform for novel surface‐enhanced molecular identification. Particularly, graphene shows exciting opportunities for biosensing applications due to its versatile functionalization methods with different biomolecular building blocks (e.g., enzymes, proteins, and DNA). Here, a quantitative bioassay based on the mid‐IR localized surface plasmon resonance (LSPR) modulation in functionalized graphene nanostructures is demonstrated. Specifically, vitamin B12 (vB12) using the specific recognition elements on modified graphene nanoribbons (i.e., pyrene linkers via π − π stacking + anti‐vB12 antibody fragments via amide bond) is detected. Different concentrations of vB12 spotted on an arrayed panel of a single chip are quantified by the graphene LSPR shifts, where a limit of detection (LOD) of 53.5 ng mL−1 is obtained. The upscaling potential of the bioassay using large area nanostructured graphene films produced by nanoimprinting 2D hole arrays is illustrated. The integration of quantitative bioassay with scalable graphene nanostructures shows promising routes of graphene‐based mid‐IR platforms toward prospective industrial applications.